Galectin Therapeutics Inc (NAS:GALT)
$ 2.605 0.08 (3.17%) Market Cap: 162.24 Mil Enterprise Value: 227.34 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 36/100

Galectin Therapeutics Inc Annual Shareholders Meeting Transcript

Dec 03, 2021 / 04:00PM GMT
Release Date Price: $2.28 (-6.94%)
Operator

Welcome to the Annual Meeting for Galectin Therapeutics, Inc. Our host for today's call is Kevin Freeman, Vice Chairman. At this time, all participants will be in a listen-only mode.

I will now turn the call over to your host, Mr. Freeman. You may begin, sir.

Kevin Freeman
Galectin Therapeutics, Inc. - Vice Chairman of the Board

Good morning, ladies and gentlemen. Welcome. My name is Kevin Freeman. I am the Vice Chairman of the Board of Galectin Therapeutics, Inc. I will act as the Chair of this meeting, and Mr. Jack Callicutt, our Chief Financial Officer and Corporate Secretary, will act as Secretary.

Due to the ongoing COVID-19 pandemic, we are holding this year's Annual Meeting as a virtual meeting. Stockholders who require technical assistance during the meeting can call Broadridge's technical support line at the number listed on our virtual meeting website. Thank you.

I hereby call the 2021 Annual Meeting for Galectin Therapeutics, Inc. to order. At this time, I would like to introduce the current members of the Board of

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot